Caged protein nanoparticles for drug delivery.

Area of Science:

• Biotechnology and Nanomedicine
• Protein Engineering
• Drug Delivery Systems

Background:

• Protein nanoparticles exhibit advantageous characteristics for drug delivery, including optimal size for cellular uptake (endocytosis), biocompatibility, and biodegradability.
• These nanoparticles offer unique functionalization capabilities at external, internal, and inter-subunit interfaces, enabling precise control over drug loading and release.

Purpose of the Study:

• To review the diverse applications of protein nanoparticles in drug delivery, focusing on their structural advantages and functionalization potential.
• To explore how protein nanoparticles are engineered for targeted delivery, controlled release, and immunomodulation.
• To discuss the factors influencing effective drug delivery using these platforms, including targeting, cellular uptake, release kinetics, and systemic clearance.

Main Methods:

• Review of existing literature on protein nanoparticle design and application in drug delivery.
• Analysis of covalent and non-covalent loading strategies for therapeutic molecules.
• Examination of release mechanisms triggered by specific microenvironments.

Main Results:

• Protein nanoparticles can be engineered for efficient loading and targeted release of various therapeutic molecules.
• The immunomodulatory potential of protein nanoparticles is being leveraged for novel therapeutic strategies.
• Successful drug delivery is contingent upon optimizing targeting, cellular uptake, release kinetics, and systemic clearance.

Conclusions:

• Protein nanoparticles represent a promising platform for advanced drug delivery due to their tunable properties and biocompatibility.
• The ability to exploit the immune system's response to proteins opens new avenues for immunomodulatory therapies.
• Further research into diverse drug loading, release mechanisms, and therapeutic targets will expand the utility of these nanocarriers.